[go: up one dir, main page]

AU2001245489A1 - Human single nucleotide polymorphisms - Google Patents

Human single nucleotide polymorphisms

Info

Publication number
AU2001245489A1
AU2001245489A1 AU2001245489A AU4548901A AU2001245489A1 AU 2001245489 A1 AU2001245489 A1 AU 2001245489A1 AU 2001245489 A AU2001245489 A AU 2001245489A AU 4548901 A AU4548901 A AU 4548901A AU 2001245489 A1 AU2001245489 A1 AU 2001245489A1
Authority
AU
Australia
Prior art keywords
single nucleotide
nucleotide polymorphisms
human single
human
polymorphisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245489A
Inventor
Michele Cargill
James S. Ireland
Eric S. Lander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitehead Institute for Biomedical Research
Original Assignee
Whitehead Institute for Biomedical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Institute for Biomedical Research filed Critical Whitehead Institute for Biomedical Research
Publication of AU2001245489A1 publication Critical patent/AU2001245489A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001245489A 2000-03-07 2001-03-07 Human single nucleotide polymorphisms Abandoned AU2001245489A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18751000P 2000-03-07 2000-03-07
US60/187,510 2000-03-07
US20612900P 2000-05-22 2000-05-22
US60/206,129 2000-05-22
PCT/US2001/007268 WO2001066800A2 (en) 2000-03-07 2001-03-07 Human single nucleotide polymorphisms

Publications (1)

Publication Number Publication Date
AU2001245489A1 true AU2001245489A1 (en) 2001-09-17

Family

ID=26883100

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245489A Abandoned AU2001245489A1 (en) 2000-03-07 2001-03-07 Human single nucleotide polymorphisms

Country Status (3)

Country Link
US (1) US20020032319A1 (en)
AU (1) AU2001245489A1 (en)
WO (1) WO2001066800A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100896A2 (en) * 2001-06-13 2002-12-19 Centre National De La Recherche Scientifique (C.N.R.S.) Method for diagnosing cancer susceptibility
CA2498418A1 (en) * 2002-09-10 2004-03-25 Guennadi V. Glinskii Gene segregation and biological sample classification methods
CA2941594C (en) * 2002-12-20 2021-07-06 Celera Corporation Genetic polymorphisms of the protein receptor c (procr) associated with myocardial infarction, methods of detection and uses thereof
US20040229269A1 (en) * 2003-05-15 2004-11-18 Ghazala Hashmi Hybridization-mediated analysis of polymorphisms
WO2005049860A2 (en) * 2003-11-05 2005-06-02 Karolinska Innovations Ab Diagnostic and therapeutic methods and assays
PT2305221E (en) * 2003-12-01 2015-09-03 Cancer Res Inst Dna damage repair inhibitors for treatment of cancer
US8093004B2 (en) * 2004-04-28 2012-01-10 Council Of Scientific & Industrial Research Method of detecting and predicting bronchodilatory response to beta agonist
JP2008502341A (en) * 2004-06-14 2008-01-31 アンテグラジャン Human obesity susceptibility gene encoding voltage-gated potassium channel and use thereof
US7323308B2 (en) * 2004-09-03 2008-01-29 Affymetrix, Inc. Methods of genetic analysis of E. coli
AU2005314461B2 (en) * 2004-11-18 2012-02-02 The Rockefeller University Methods and compositions for treating ocular disorders
GB2424886A (en) 2005-04-04 2006-10-11 Dxs Ltd Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
FI20050640A0 (en) * 2005-06-16 2005-06-16 Faron Pharmaceuticals Oy Compounds for treating or preventing diseases or disorders related to amine oxidases
US7666584B2 (en) * 2005-09-01 2010-02-23 Philadelphia Health & Education Coporation Identification of a pin specific gene and protein (PIN-1) useful as a diagnostic treatment for prostate cancer
US20070092892A1 (en) * 2005-09-02 2007-04-26 Willey James C Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states
JP7558167B2 (en) 2018-12-03 2024-09-30 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Oligobenzamide analogs and their use in cancer treatment - Patents.com

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726905B1 (en) * 1993-11-03 2005-03-23 Orchid BioSciences, Inc. Single nucleotide polymorphisms and their use in genetic analysis
EP0941366A2 (en) * 1996-11-06 1999-09-15 Whitehead Institute For Biomedical Research Biallelic markers

Also Published As

Publication number Publication date
WO2001066800A3 (en) 2003-06-05
WO2001066800A8 (en) 2002-02-14
WO2001066800A2 (en) 2001-09-13
US20020032319A1 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU2001238030A1 (en) Detection of single nucleotide polymorphisms
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU2001245489A1 (en) Human single nucleotide polymorphisms
AUPQ008799A0 (en) Genome sequencing
AU2001241910A1 (en) Distributed least choice first arbiter
AU2376200A (en) Insulin-synthesis genes
AU2258601A (en) Ibd-related polymorphisms
AU1773501A (en) Human single nucleotide polymorphisms
AU7461900A (en) Nucleotide sequences
AU6382000A (en) Genome analysis
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU2002249793A1 (en) Human single nucleotide polymorphisms
AU2002324955A1 (en) Regulatory single nucleotide polymorphisms and methods therefor
AUPR282501A0 (en) Expression facilitating nucleotides
AU2002214446A1 (en) Single nucleotide polymorphisms
AU2001290603A1 (en) Haplotypes of the or11a1 gene
AU2001270296A1 (en) Haplotypes of the mc2r gene
AU2001266759A1 (en) Haplotypes of the acp2 gene
AU2002213185A1 (en) Haplotypes of the chrm5 gene
AU2001273117A1 (en) Haplotypes of the appbp1 gene
AU2001274995A1 (en) Haplotypes of the rlbp1 gene
AU2001286644A1 (en) Haplotypes of the gng7 gene
AU2001249650A1 (en) Haplotypes of the chrnb3 gene
AU2002227177A1 (en) Haplotypes of the scya21 gene